Application 021447
- Type
- NDA
- Sponsor
- COVIS PHARMA BV
Application Products#
| Product | Drug | Ingredient | Form | Strength | Reference drug | Reference standard |
|---|---|---|---|---|---|---|
| 001 | ZANAFLEX | TIZANIDINE HYDROCHLORIDE | CAPSULE;ORAL | EQ 2MG BASE | Yes | No |
| 002 | ZANAFLEX | TIZANIDINE HYDROCHLORIDE | CAPSULE;ORAL | EQ 4MG BASE | Yes | No |
| 003 | ZANAFLEX | TIZANIDINE HYDROCHLORIDE | CAPSULE;ORAL | EQ 6MG BASE | Yes | Yes |
Orange Book products#
| Application-product | Trade name | Ingredient | Strength | Dosage form / route | TE codes | RLD / RS | Approval date |
|---|---|---|---|---|---|---|---|
| N021447-001 | ZANAFLEX | TIZANIDINE HYDROCHLORIDE | EQ 2MG BASE | CAPSULE / ORAL | AB | RLD | 2002-08-29 |
| N021447-002 | ZANAFLEX | TIZANIDINE HYDROCHLORIDE | EQ 4MG BASE | CAPSULE / ORAL | AB | RLD, RS | 2002-08-29 |
| N021447-003 | ZANAFLEX | TIZANIDINE HYDROCHLORIDE | EQ 6MG BASE | CAPSULE / ORAL | AB | RLD | 2002-08-29 |
Therapeutic equivalence codes#
| Application-product | TE code |
|---|---|
| N021447-001 | AB |
| N021447-002 | AB |
| N021447-003 | AB |
Observed Orange Book product history#
Observed FDA ZIP history: Each table is queried independently by exact application/product key from successfully parsed Orange Book snapshots. Capture times identify archived source observations; absence or a change between snapshots is not inferred. FDA publication files that were not recoverable as structured ZIP data are not represented as states.
| Captured | Edition | Application-product | Trade name | Strength | Dosage form / route | Product TE source text | RLD / RS | Approval date | Source SHA-256 |
|---|---|---|---|---|---|---|---|---|---|
| 2026-08-18 06:07:40 | 2026-07 | N021447-001 | ZANAFLEX | EQ 2MG BASE | CAPSULE / ORAL | AB | RLD | 2002-08-29 | caaa826d4ba7… |
| 2026-08-18 06:07:40 | 2026-07 | N021447-002 | ZANAFLEX | EQ 4MG BASE | CAPSULE / ORAL | AB | RLD, RS | 2002-08-29 | caaa826d4ba7… |
| 2026-08-18 06:07:40 | 2026-07 | N021447-003 | ZANAFLEX | EQ 6MG BASE | CAPSULE / ORAL | AB | RLD | 2002-08-29 | caaa826d4ba7… |
| 2026-02-19 14:30 UTC | 2026-02 | N021447-001 | ZANAFLEX | EQ 2MG BASE | CAPSULE / ORAL | AB | RLD | 2002-08-29 | 011fe1cb6892… |
| 2026-02-19 14:30 UTC | 2026-02 | N021447-002 | ZANAFLEX | EQ 4MG BASE | CAPSULE / ORAL | AB | RLD | 2002-08-29 | 011fe1cb6892… |
| 2026-02-19 14:30 UTC | 2026-02 | N021447-003 | ZANAFLEX | EQ 6MG BASE | CAPSULE / ORAL | AB | RLD, RS | 2002-08-29 | 011fe1cb6892… |
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | N021447-001 | ZANAFLEX | EQ 2MG BASE | CAPSULE / ORAL | AB | RLD | 2002-08-29 | 31067a03dcf5… |
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | N021447-002 | ZANAFLEX | EQ 4MG BASE | CAPSULE / ORAL | AB | RLD | 2002-08-29 | 31067a03dcf5… |
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | N021447-003 | ZANAFLEX | EQ 6MG BASE | CAPSULE / ORAL | AB | RLD, RS | 2002-08-29 | 31067a03dcf5… |
| 2025-08-23 18:47 UTC | 2025-08 | N021447-001 | ZANAFLEX | EQ 2MG BASE | CAPSULE / ORAL | AB | RLD | 2002-08-29 | 6a471c1ec25d… |
| 2025-08-23 18:47 UTC | 2025-08 | N021447-002 | ZANAFLEX | EQ 4MG BASE | CAPSULE / ORAL | AB | RLD | 2002-08-29 | 6a471c1ec25d… |
| 2025-08-23 18:47 UTC | 2025-08 | N021447-003 | ZANAFLEX | EQ 6MG BASE | CAPSULE / ORAL | AB | RLD, RS | 2002-08-29 | 6a471c1ec25d… |
| 2025-03-22 03:13 UTC · 3 captures of this ZIP | 2025-03 | N021447-001 | ZANAFLEX | EQ 2MG BASE | CAPSULE / ORAL | AB | RLD | 2002-08-29 | fd3edfee7708… |
| 2025-03-22 03:13 UTC · 3 captures of this ZIP | 2025-03 | N021447-002 | ZANAFLEX | EQ 4MG BASE | CAPSULE / ORAL | AB | RLD | 2002-08-29 | fd3edfee7708… |
| 2025-03-22 03:13 UTC · 3 captures of this ZIP | 2025-03 | N021447-003 | ZANAFLEX | EQ 6MG BASE | CAPSULE / ORAL | AB | RLD, RS | 2002-08-29 | fd3edfee7708… |
| 2025-02-26 10:13 UTC · 3 captures of this ZIP | 2025-02 | N021447-001 | ZANAFLEX | EQ 2MG BASE | CAPSULE / ORAL | AB | RLD | 2002-08-29 | b8a1b40f171c… |
| 2025-02-26 10:13 UTC · 3 captures of this ZIP | 2025-02 | N021447-002 | ZANAFLEX | EQ 4MG BASE | CAPSULE / ORAL | AB | RLD | 2002-08-29 | b8a1b40f171c… |
| 2025-02-26 10:13 UTC · 3 captures of this ZIP | 2025-02 | N021447-003 | ZANAFLEX | EQ 6MG BASE | CAPSULE / ORAL | AB | RLD, RS | 2002-08-29 | b8a1b40f171c… |
| 2025-01-19 17:59 UTC · 7 captures of this ZIP | 2025-01 | N021447-001 | ZANAFLEX | EQ 2MG BASE | CAPSULE / ORAL | AB | RLD | 2002-08-29 | 03ed91905a0d… |
| 2025-01-19 17:59 UTC · 7 captures of this ZIP | 2025-01 | N021447-002 | ZANAFLEX | EQ 4MG BASE | CAPSULE / ORAL | AB | RLD | 2002-08-29 | 03ed91905a0d… |
| 2025-01-19 17:59 UTC · 7 captures of this ZIP | 2025-01 | N021447-003 | ZANAFLEX | EQ 6MG BASE | CAPSULE / ORAL | AB | RLD, RS | 2002-08-29 | 03ed91905a0d… |
| 2024-12-13 21:23 UTC · 2 captures of this ZIP | 2024-12 | N021447-001 | ZANAFLEX | EQ 2MG BASE | CAPSULE / ORAL | AB | RLD | 2002-08-29 | 2680178bc6a6… |
| 2024-12-13 21:23 UTC · 2 captures of this ZIP | 2024-12 | N021447-002 | ZANAFLEX | EQ 4MG BASE | CAPSULE / ORAL | AB | RLD | 2002-08-29 | 2680178bc6a6… |
| 2024-12-13 21:23 UTC · 2 captures of this ZIP | 2024-12 | N021447-003 | ZANAFLEX | EQ 6MG BASE | CAPSULE / ORAL | AB | RLD, RS | 2002-08-29 | 2680178bc6a6… |
| 2024-09-14 05:58 UTC · 2 captures of this ZIP | 2024-09 | N021447-001 | ZANAFLEX | EQ 2MG BASE | CAPSULE / ORAL | AB | RLD | 2002-08-29 | 5bbf6a4d5a75… |
| 2024-09-14 05:58 UTC · 2 captures of this ZIP | 2024-09 | N021447-002 | ZANAFLEX | EQ 4MG BASE | CAPSULE / ORAL | AB | RLD | 2002-08-29 | 5bbf6a4d5a75… |
| 2024-09-14 05:58 UTC · 2 captures of this ZIP | 2024-09 | N021447-003 | ZANAFLEX | EQ 6MG BASE | CAPSULE / ORAL | AB | RLD, RS | 2002-08-29 | 5bbf6a4d5a75… |
| 2024-11-08 22:44 UTC · 3 captures of this ZIP | 2024-11 | N021447-001 | ZANAFLEX | EQ 2MG BASE | CAPSULE / ORAL | AB | RLD | 2002-08-29 | d8e5a09893c0… |
| 2024-11-08 22:44 UTC · 3 captures of this ZIP | 2024-11 | N021447-002 | ZANAFLEX | EQ 4MG BASE | CAPSULE / ORAL | AB | RLD | 2002-08-29 | d8e5a09893c0… |
| 2024-11-08 22:44 UTC · 3 captures of this ZIP | 2024-11 | N021447-003 | ZANAFLEX | EQ 6MG BASE | CAPSULE / ORAL | AB | RLD, RS | 2002-08-29 | d8e5a09893c0… |
| 2024-10-29 15:01 UTC | 2024-10 | N021447-001 | ZANAFLEX | EQ 2MG BASE | CAPSULE / ORAL | AB | RLD | 2002-08-29 | d06236e962d9… |
| 2024-10-29 15:01 UTC | 2024-10 | N021447-002 | ZANAFLEX | EQ 4MG BASE | CAPSULE / ORAL | AB | RLD | 2002-08-29 | d06236e962d9… |
| 2024-10-29 15:01 UTC | 2024-10 | N021447-003 | ZANAFLEX | EQ 6MG BASE | CAPSULE / ORAL | AB | RLD, RS | 2002-08-29 | d06236e962d9… |
| 2024-08-13 05:28 UTC · 3 captures of this ZIP | 2024-08 | N021447-001 | ZANAFLEX | EQ 2MG BASE | CAPSULE / ORAL | AB | RLD | 2002-08-29 | 79d66fd596c7… |
| 2024-08-13 05:28 UTC · 3 captures of this ZIP | 2024-08 | N021447-002 | ZANAFLEX | EQ 4MG BASE | CAPSULE / ORAL | AB | RLD | 2002-08-29 | 79d66fd596c7… |
| 2024-08-13 05:28 UTC · 3 captures of this ZIP | 2024-08 | N021447-003 | ZANAFLEX | EQ 6MG BASE | CAPSULE / ORAL | AB | RLD, RS | 2002-08-29 | 79d66fd596c7… |
| 2024-07-13 05:37 UTC · 2 captures of this ZIP | 2024-07 | N021447-001 | ZANAFLEX | EQ 2MG BASE | CAPSULE / ORAL | AB | RLD | 2002-08-29 | 301d65b070ca… |
| 2024-07-13 05:37 UTC · 2 captures of this ZIP | 2024-07 | N021447-002 | ZANAFLEX | EQ 4MG BASE | CAPSULE / ORAL | AB | RLD | 2002-08-29 | 301d65b070ca… |
| 2024-07-13 05:37 UTC · 2 captures of this ZIP | 2024-07 | N021447-003 | ZANAFLEX | EQ 6MG BASE | CAPSULE / ORAL | AB | RLD, RS | 2002-08-29 | 301d65b070ca… |
| 2024-06-18 03:08 UTC · 5 captures of this ZIP | 2024-06 | N021447-001 | ZANAFLEX | EQ 2MG BASE | CAPSULE / ORAL | AB | RLD | 2002-08-29 | 1e350fbaab3a… |
Observed Orange Book normalized TE history#
| Captured | Edition | Application-product | TE code | Order | Source SHA-256 |
|---|---|---|---|---|---|
| 2026-08-18 06:07:40 | 2026-07 | N021447-001 | AB | 1 | caaa826d4ba7… |
| 2026-08-18 06:07:40 | 2026-07 | N021447-002 | AB | 1 | caaa826d4ba7… |
| 2026-08-18 06:07:40 | 2026-07 | N021447-003 | AB | 1 | caaa826d4ba7… |
| 2026-02-19 14:30 UTC | 2026-02 | N021447-001 | AB | 1 | 011fe1cb6892… |
| 2026-02-19 14:30 UTC | 2026-02 | N021447-002 | AB | 1 | 011fe1cb6892… |
| 2026-02-19 14:30 UTC | 2026-02 | N021447-003 | AB | 1 | 011fe1cb6892… |
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | N021447-001 | AB | 1 | 31067a03dcf5… |
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | N021447-002 | AB | 1 | 31067a03dcf5… |
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | N021447-003 | AB | 1 | 31067a03dcf5… |
| 2025-08-23 18:47 UTC | 2025-08 | N021447-001 | AB | 1 | 6a471c1ec25d… |
| 2025-08-23 18:47 UTC | 2025-08 | N021447-002 | AB | 1 | 6a471c1ec25d… |
| 2025-08-23 18:47 UTC | 2025-08 | N021447-003 | AB | 1 | 6a471c1ec25d… |
| 2025-03-22 03:13 UTC · 3 captures of this ZIP | 2025-03 | N021447-001 | AB | 1 | fd3edfee7708… |
| 2025-03-22 03:13 UTC · 3 captures of this ZIP | 2025-03 | N021447-002 | AB | 1 | fd3edfee7708… |
| 2025-03-22 03:13 UTC · 3 captures of this ZIP | 2025-03 | N021447-003 | AB | 1 | fd3edfee7708… |
| 2025-02-26 10:13 UTC · 3 captures of this ZIP | 2025-02 | N021447-001 | AB | 1 | b8a1b40f171c… |
| 2025-02-26 10:13 UTC · 3 captures of this ZIP | 2025-02 | N021447-002 | AB | 1 | b8a1b40f171c… |
| 2025-02-26 10:13 UTC · 3 captures of this ZIP | 2025-02 | N021447-003 | AB | 1 | b8a1b40f171c… |
| 2025-01-19 17:59 UTC · 7 captures of this ZIP | 2025-01 | N021447-001 | AB | 1 | 03ed91905a0d… |
| 2025-01-19 17:59 UTC · 7 captures of this ZIP | 2025-01 | N021447-002 | AB | 1 | 03ed91905a0d… |
| 2025-01-19 17:59 UTC · 7 captures of this ZIP | 2025-01 | N021447-003 | AB | 1 | 03ed91905a0d… |
| 2024-12-13 21:23 UTC · 2 captures of this ZIP | 2024-12 | N021447-001 | AB | 1 | 2680178bc6a6… |
| 2024-12-13 21:23 UTC · 2 captures of this ZIP | 2024-12 | N021447-002 | AB | 1 | 2680178bc6a6… |
| 2024-12-13 21:23 UTC · 2 captures of this ZIP | 2024-12 | N021447-003 | AB | 1 | 2680178bc6a6… |
| 2024-09-14 05:58 UTC · 2 captures of this ZIP | 2024-09 | N021447-001 | AB | 1 | 5bbf6a4d5a75… |
| 2024-09-14 05:58 UTC · 2 captures of this ZIP | 2024-09 | N021447-002 | AB | 1 | 5bbf6a4d5a75… |
| 2024-09-14 05:58 UTC · 2 captures of this ZIP | 2024-09 | N021447-003 | AB | 1 | 5bbf6a4d5a75… |
| 2024-11-08 22:44 UTC · 3 captures of this ZIP | 2024-11 | N021447-001 | AB | 1 | d8e5a09893c0… |
| 2024-11-08 22:44 UTC · 3 captures of this ZIP | 2024-11 | N021447-002 | AB | 1 | d8e5a09893c0… |
| 2024-11-08 22:44 UTC · 3 captures of this ZIP | 2024-11 | N021447-003 | AB | 1 | d8e5a09893c0… |
| 2024-10-29 15:01 UTC | 2024-10 | N021447-001 | AB | 1 | d06236e962d9… |
| 2024-10-29 15:01 UTC | 2024-10 | N021447-002 | AB | 1 | d06236e962d9… |
| 2024-10-29 15:01 UTC | 2024-10 | N021447-003 | AB | 1 | d06236e962d9… |
| 2024-08-13 05:28 UTC · 3 captures of this ZIP | 2024-08 | N021447-001 | AB | 1 | 79d66fd596c7… |
| 2024-08-13 05:28 UTC · 3 captures of this ZIP | 2024-08 | N021447-002 | AB | 1 | 79d66fd596c7… |
| 2024-08-13 05:28 UTC · 3 captures of this ZIP | 2024-08 | N021447-003 | AB | 1 | 79d66fd596c7… |
| 2024-07-13 05:37 UTC · 2 captures of this ZIP | 2024-07 | N021447-001 | AB | 1 | 301d65b070ca… |
| 2024-07-13 05:37 UTC · 2 captures of this ZIP | 2024-07 | N021447-002 | AB | 1 | 301d65b070ca… |
| 2024-07-13 05:37 UTC · 2 captures of this ZIP | 2024-07 | N021447-003 | AB | 1 | 301d65b070ca… |
| 2024-06-18 03:08 UTC · 5 captures of this ZIP | 2024-06 | N021447-001 | AB | 1 | 1e350fbaab3a… |
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Zanaflex | TIZANIDINE HYDROCHLORIDE | Legacy Pharma USA, Inc. | 60c27d35-7349-4fc6-86ad-70fffdbe3e08 | 2026-01-02 | Warnings, Adverse reactions | 021447 NDA021447 |
| Zanaflex | TIZANIDINE HYDROCHLORIDE | Covis Pharma US, Inc | 043d9e51-bfa2-4add-9058-5ece332f7e99 | 2025-05-05 | Warnings, Adverse reactions | 021447 NDA021447 70515-604 70515-606 70515-602 |
| tizanidine hydrochloride | TIZANIDINE HYDROCHLORIDE | Actavis Pharma, Inc. | cb8b01b3-bcec-4762-9d67-0db018ef6b22 | 2023-03-10 | Warnings, Adverse reactions | 021447 NDA021447 0591-2789 0591-2790 0591-2788 |
NDC Listings For This Application#
| NDC | Name | Nonproprietary name | Labeler | Marketing category | Status |
|---|---|---|---|---|---|
| 0591-2788 | tizanidine hydrochloride | tizanidine hydrochloride | Actavis Pharma, Inc. | NDA | Current |
| 0591-2788 | tizanidine hydrochloride | tizanidine hydrochloride | Actavis Pharma, Inc. | NDA | Current |
| 0591-2788 | tizanidine hydrochloride | tizanidine hydrochloride | Actavis Pharma, Inc. | NDA | Current |
| 0591-2788 | tizanidine hydrochloride | tizanidine hydrochloride | Actavis Pharma, Inc. | NDA | Current |
| 0591-2788 | tizanidine hydrochloride | tizanidine hydrochloride | Actavis Pharma, Inc. | NDA | Current |
| 0591-2789 | tizanidine hydrochloride | tizanidine hydrochloride | Actavis Pharma, Inc. | NDA | Current |
| 0591-2789 | tizanidine hydrochloride | tizanidine hydrochloride | Actavis Pharma, Inc. | NDA | Current |
| 0591-2789 | tizanidine hydrochloride | tizanidine hydrochloride | Actavis Pharma, Inc. | NDA | Current |
| 0591-2789 | tizanidine hydrochloride | tizanidine hydrochloride | Actavis Pharma, Inc. | NDA | Current |
| 0591-2789 | tizanidine hydrochloride | tizanidine hydrochloride | Actavis Pharma, Inc. | NDA | Current |
| 0591-2790 | tizanidine hydrochloride | tizanidine hydrochloride | Actavis Pharma, Inc. | NDA | Current |
| 0591-2790 | tizanidine hydrochloride | tizanidine hydrochloride | Actavis Pharma, Inc. | NDA | Current |
| 0591-2790 | tizanidine hydrochloride | tizanidine hydrochloride | Actavis Pharma, Inc. | NDA | Current |
| 0591-2790 | tizanidine hydrochloride | tizanidine hydrochloride | Actavis Pharma, Inc. | NDA | Current |
| 0591-2790 | tizanidine hydrochloride | tizanidine hydrochloride | Actavis Pharma, Inc. | NDA | Current |
| 10144-602 | Zanaflex | tizanidine hydrochloride | Acorda Therapeutics, Inc. | NDA | Current |
| 10144-604 | Zanaflex | tizanidine hydrochloride | Acorda Therapeutics, Inc. | NDA | Current |
| 10144-606 | Zanaflex | tizanidine hydrochloride | Acorda Therapeutics, Inc. | NDA | Current |
| 21695-373 | Zanaflex | tizanidine hydrochloride | Rebel Distributors Corp | NDA | Current |
| 55700-259 | tizanidine hydrochloride | tizanidine hydrochloride | Lake Erie Medical DBA Quality Care Products LLC | NDA | Current |
| 55700-259 | tizanidine hydrochloride | tizanidine hydrochloride | Lake Erie Medical DBA Quality Care Products LLC | NDA | Current |
| 63629-5139 | tizanidine hydrochloride | tizanidine hydrochloride | Bryant Ranch Prepack | NDA | Current |
| 63629-5139 | tizanidine hydrochloride | tizanidine hydrochloride | Bryant Ranch Prepack | NDA | Current |
| 70515-602 | Zanaflex | tizanidine hydrochloride | Covis Pharma US, Inc | NDA | Current |
| 70515-602 | Zanaflex | tizanidine hydrochloride | Covis Pharma | NDA | Current |
| 70515-602 | Zanaflex | tizanidine hydrochloride | Covis Pharma | NDA | Current |
| 70515-604 | Zanaflex | tizanidine hydrochloride | Covis Pharma US, Inc | NDA | Current |
| 70515-604 | Zanaflex | tizanidine hydrochloride | Covis Pharma | NDA | Current |
| 70515-604 | Zanaflex | tizanidine hydrochloride | Covis Pharma | NDA | Current |
| 70515-606 | Zanaflex | tizanidine hydrochloride | Covis Pharma US, Inc | NDA | Current |
| 70515-606 | Zanaflex | tizanidine hydrochloride | Covis Pharma | NDA | Current |
| 70515-606 | Zanaflex | tizanidine hydrochloride | Covis Pharma | NDA | Current |
Documents#
| Document | Submission type | Date |
|---|---|---|
| 80332 | SUPPL | 2025-01-21 |
| 80433 | SUPPL | 2024-11-26 |
| 65690 | SUPPL | 2020-12-22 |
| 65669 | SUPPL | 2020-12-22 |
| 36966 | SUPPL | 2013-11-08 |
| 27827 | SUPPL | 2013-11-08 |
| 5419 | SUPPL | 2013-03-11 |
| 15505 | SUPPL | 2006-08-04 |
| 5418 | SUPPL | 2006-08-04 |
| 21667 | ORIG | 2004-03-24 |
| 27826 | ORIG | 2003-05-30 |
| 15504 | ORIG | 2002-08-29 |